CX 2015 Lombard 2016-10-12T13:00:54+00:00


Wednesday 29 April

London Room Learning Centre

Meeting the challenges of EVAR with a unique design & proven indication: early-, mid-, and late-term clinical experience with Aorfix

Chairman: Peter Phillips, Lombard Medical

Two-year outcomes from the US PYTHAGORAS PMA trial
Mark Fillinger, Dartmouth, USA

The ARCHYTAS worldwide post-market registry
Vincent Riambau, Barcelona, Spain

European experience using the Aorfix endograft in complex EVAR
Nilo Mosquera, Ourense, Spain

Why Aorfix fits your practice: the US experience to date
Robert Beasley, New York, USA

Choosing the right device for your patients: when aorfix meets the challenge
Andrew Holden, Auckland, New Zealand